This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Roche Holding AG
Drug Names(s): Ro27-2441
Description: R411 is an oral dual alpha4beta1-alpha4beta7 integrin antagonist. These integrins are receptors that promote migration, activation, and increasedsurvival of inflammatory cells in the lung. They are found particular on Th2 lymphocytes, eosinophils and mast cells.
Additional information available to subscribers only: